Bavarian Nordic raises sales guidance after monkeypox vaccine orderTherapeuticsDanish biotechnology company Bavarian Nordic on Wednesday lifted the company’s sales outlook and now expects a smaller operating loss this year after signing a contract with an undisclosed country for the supply of its monkeypox vaccine. Read more May 25, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/05/ReutersBarvarianNordic5-25-2022.jpg 792 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-05-25 07:00:022022-05-25 12:17:16Bavarian Nordic raises sales guidance after monkeypox vaccine order